Aptose Biosciences, Inc. (APTO) Financials
APTO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 20.9 million | 13.1 million |
2023-06-30 | 26.6 million | 12.8 million |
2023-03-31 | 39.3 million | 13.3 million |
2022-12-31 | 51.0 million | 13.3 million |
APTO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -10.5 million | 599000 |
2023-06-30 | -13.5 million | 769000 |
2023-03-31 | -11.3 million | 1.9 million |
2022-12-31 | -8.6 million | 861000 |
APTO Net Income
No data available :(
APTO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 17.7 million | - | 1.1 million |
2023-06-30 | 23.3 million | - | 1.2 million |
2023-03-31 | 35.7 million | - | 1.2 million |
2022-12-31 | 47.0 million | - | 1.3 million |
APTO Shares Outstanding
APTO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 19 | 8.3 million | 3.4 million | - |
2023-06-30 | 29000 | 10.6 million | 3.9 million | - |
2023-03-31 | 29000 | 8.8 million | 5.3 million | - |
2022-12-31 | 16000 | 6.8 million | 3.6 million | - |
APTO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 109590 |
2023-06-30 | - | 115504 |
2023-03-31 | - | 131009 |
2022-12-31 | - | 100151 |
APTO
Price: $1.21
52 week price:
Earnings Per Share: -7.72 USD
P/E Ratio: -0.27
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 268562
Ebitda: -2.7 millionMarket Capitalization: 22.4 million